Upcoming EL-PFDD Meetings

Revance Therapeutics – 7/15/2022. Country: USA. Record Type: 483

GE HealthCare issues updated use instructions for certain Carestation 600 and 700 series Anesthesia Systems

FOR IMMEDIATE RELEASE – December 10, 2025 – Albuquerque, New Mexico, MediNatura New Mexico, Inc. is voluntarily recalling one lot of ReBoost Nasal Spray to the consumer level. The product has been found to contain yeast/mold and microbial contamination with one species identified as Achromobacter, a

CGMP/Finished Pharmaceuticals/Adulterated

It has become increasingly clear that new approach methodologies (NAMs)—when combined with knowledge of the pathway, results of pharmacology studies, and other relevant data—may offer ways to reduce animal testing.

FDA’s surrogate endpoint table provides valuable information for drug developers on endpoints that may be considered and discussed with FDA for individual development programs.